1 active trials 1 recruiting 1 disease areas 3 changes in 30 days
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT04055649 | ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian… | Malignant Ovarian Epithelial Tumor | Recruiting | 2026-06-17 |
Ovarian Cancer (1)